Rationale and design of the GOLDEN BRIDGE II: a cluster-randomised multifaceted intervention trial of an artificial intelligence-based cerebrovascular disease clinical decision support system to improve stroke outcomes and care quality in China
Related Posts
Sahashi Y, Vukadinovic M, Amrollahi F, Trivedi H, Rhee J, Chen J, Cheng S, Ouyang D, Kwan AC. Opportunistic Screening of Chronic Liver Disease with[...]
Al-Jarshawi M, Martin GP, Cole A, Menezes MN, Cheng RK, Lopez-Mattei J, Yang EH, Mamas MA. Prognostic significance of abdominal aortic calcification scores on dual-energy[...]
Boström KI, Yao Y. Response by Boström and Yao to Letter Regarding Article, "Arterial-Lymphatic-Like Endothelial Cells Appear in Hereditary Hemorrhagic Telangiectasia 2 and Contribute to[...]